Author:
Mathiot C.,Teillaud J. -L.,Elmalek M.,Mosseri V.,Euller-Ziegler L.,Daragon A.,Grosbois B.,Michaux J. -L.,Facon T.,Bernard J. -F.,Duclos B.,Monconduit M.,Fridman W. H.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference32 articles.
1. Durie BGM, Salmon SS: A clinical staging system for multiple myeloma. Cancer 36:842?854, 1975
2. Durie BGM: Staging and kinetics of multiple myeloma. Semin Oncol 13:300?309, 1986
3. Greipp PR, Katzmann JA, O'Fallon WM, Kyle RA: Value of ?2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma. Blood 72:219?223, 1988
4. Durie BGM, Stock-Novack D, Salmon SE, Finley P, Backord J, Crowley J, Coltman CA: Prognostic value of pretreatment serum ?2-microglobulin in myeloma: A Southwest Oncology Group study Blood 75:823?830, 1990
5. Scarffe JH, Anderson H, Palmer MK, Crowther D: Prognostic significance of pretreatment serum ?2-microglobulin levels in multiple myeloma. Eur J Cancer Clin Oncol 19:1361?1364, 1983
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献